Registration and Disclosure of Clinical Trial Results in External Public Registries
Janssen publicly discloses information about its clinical trials in external public registries, such as clinicaltrials.gov. These disclosure include:
- Registering all pharmaceutical clinical trials conducted in patients (Phase 1b through phase 4) on external registries in accordance with specified requirements.
- Upon receiving regulatory approval, disclosing clinical trial results of investigational studies in accordance with specific format and timeframe of local laws and regulations.
- Disclosing company-sponsored pharmaceutical clinical trial results of approved products within one year of study completion, in accordance with and within the timeframe of applicable laws and regulations.